Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists Devise New Screening Method to Aid RNA Drug Development Research

10.10.2012
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new method of screening more than three million combinations of interactions between RNA and small molecules to identify the best targets on RNA as well as the most promising potential drug compounds. This novel technology may lead to more efficient drug development.
The study was published in the October 9, 2012 issue of the journal Nature Communications.

RNA has multiple biological functions, including encoding and translating proteins from genes and regulating the amount of protein expressed under various cellular conditions. Recent studies have identified RNA as a “molecular switch” that controls cellular events such as gene expression, making RNA an attractive target for small molecules that serve as chemical genetics probes, analytical tools or potential drugs.
However, to date information on which small molecules bind to which parts (structural motifs) of RNA has been sparse, hampering this promising area of research and development. That’s where the new study comes in.

“For the first time we have been able to probe what types of small molecules would be good lead drugs to target RNA by probing millions of RNA-ligand combinations,” said Matthew Disney, an associate professor at TSRI who authored the study with graduate student Tuan Tran. “In a viral genome, for example, RNA folds such as hairpin loops contribute to disease, but we don’t know which hairpin loops should we focus on. In the study, we were able to define those RNA motifs, including hairpin loops, that bind to small molecules and the types of small molecules that bind to RNA.”

Disney notes that larger, more chemically diverse small molecule libraries could be screened to provide additional ligands with an affinity for RNA recognition, plus additional RNA motifs preferred by small molecules. The new method could be used to create easily accessible small molecule libraries biased towards binding to RNA.

The new technology will also be used in a computer program designed by Disney that brings together information on the interaction between small molecules and RNA with data on the RNA folds present in segments of the human genome that contribute to specific human diseases.

The study, “Identifying the Preferred RNA Motifs and Chemotypes that Interact by Probing Millions of Combinations,” was supported by National Institutes of Health (grant R01 GM079235), the Camille and Henry Dreyfus Foundation and the Research Corporation for Science Advancement. For more information on the study, see http://www.nature.com/ncomms/journal/v3/n10/abs/ncomms2119.html.

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. Over the past decades, Scripps Research has developed a lengthy track record of major contributions to science and health, including laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. The institute employs about 3,000 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists—including three Nobel laureates—work toward their next discoveries. The institute's graduate program, which awards Ph.D. degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu.
For information:
Office of Communications
Tel: 858-784-8134
Fax: 858-784-8136
press@scripps.edu

Eric Sauter | EurekAlert!
Further information:
http://www.scripps.edu

More articles from Life Sciences:

nachricht One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie

nachricht The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

New research could literally squeeze more power out of solar cells

20.04.2018 | Physics and Astronomy

New record on squeezing light to one atom: Atomic Lego guides light below one nanometer

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>